Glooko, Inc. Company Profile

09:49 EDT 21st April 2018 | BioPortfolio

Glooko provides insights into diabetes by enabling both people with diabetes (PWDs) and their care teams with technology to understand and manage diabetes care. Our self-management mobile app automatically syncs data from devices including blood glucose meters, insulin pumps, CGMs, smart insulin pens and many fitness and activity trackers. The broad variety of data sources provides timely and verified information, enabling PWDs and care teams to correlate insights with diet, exercise, medication and other data. We provide care teams with an easy clinic data upload solution and a population health app so they can support PWDs during and in-between office visits. Trusted by the world’s leaders in diabetes care, we are used by 7,000 providers and over 1.5 million PWDs across 23 countries in 15 languages. Learn more by visiting

News Articles [9 Associated News Articles listed on BioPortfolio]

Data show positive results for Glooko's remote diabetes management tech

Data from a six-month pilot program showed patients with type 2 diabetes who used Glooko's remote diabetes management technol -More- 

Healthcare Technology Veteran Russ Johannesson Joins Glooko as CEO

Growth and international expansion drive new addition to leadership team Glooko, the leader in diabetes data management, today announced the appointment of Russ ...

Annual Glooko Study Identifies Global Diabetes Insights

Report draws on 8.5 billion diabetes data points, one of the largest bodies of combined diabetes data in the world Glooko, the leader in diabetes data management, today releas...

FDA approves long-acting insulin titration system

The FDA has approved Glooko’s Mobile Insulin Dosing System for the titration of long-acting insulin for people with type 2 diabetes, according to a company press release.The Mobile Insulin Dosing Sy...

Strong Growth in 2017 Among Health Systems and Payers Propels Glooko into 2018

Growth to over 1.5M patients and 7,000 provider sites, account expansion, published clinical results and a strong fundraise fuel growth Glooko, the leader in diabetes d...

FDA Okays Glooko Insulin Dosing System for Type 2 Diabetes

New app allows clinicians to personalize insulin dose titration for patients and reminds them to follow instructions. Medscape Medical News

Glooko Improves Medical Group Patient Outcomes With Remote Diabetes Care Program

Sharp Rees-Stealy Medical Group increases diabetes patient engagement with Glooko Glooko, the leader in diabetes data management, today announced the results of ...

FDA Clears Glooko’s Long-Acting Insulin Titration System

Glooko’s Mobile Insulin Dosing System aims to make it easier and more effective for physicians and patients to titrate long-acting insulin between visits Glooko, ...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Glooko Enabled Remote Monitoring for Insulin-treated Patients With Type 2 Diabetes

The purpose of this study is to compare HbA1c of insulin-treated subjects with type 2 diabetes managed via usual care alone and usual care augmented with remote monitoring using Glooko

The Usability, Acceptability, and Perceived Value of the Cornerstones4Care Powered by Glooko App

This is a two-armed mixed methods study of participants (n=30) diagnosed with type 2 diabetes who use a blood glucose meter as part of their treatment regimen. Participants will have eithe...

Insulin Degludec Titration Using Mobile Insulin Dosing System

This is an open label randomized, controlled, parallel intervention study. Group 1 will receive usual care for insulin degludec titration using the STEP WISE degludec titration algorithm G...

Type 1 Diabetes Data Acquisition and Transfer Adherence Study

The purpose of this pilot study is to determine if training and support, combined with reminders to facilitate glucose data sharing with the diabetes care team in between clinic visits, ca...

Effects of a Remote Patient Monitoring Protocol on Glycemic Control in Adolescents With Type 1 Diabetes

This study will use a randomized, crossover design. Children aged 13-18 years who have been diagnosed with Type 1 diabetes for at least 1 year and with at least 2 Hemoglobin A1c values ≥...

Companies [2 Associated Companies listed on BioPortfolio]


Glooko is the leading diabetes data management platform and is trusted by the world’s leaders in diabetes care. Over 6,000 providers in 27 countries use Glooko’s FDA-cle...

Glooko, Inc.

Glooko provides insights into diabetes by enabling both people with diabetes (PWDs) and their care teams with technology to understand and manage diabetes care. Our self-managemen...

More Information about "Glooko, Inc." on BioPortfolio

We have published hundreds of Glooko, Inc. news stories on BioPortfolio along with dozens of Glooko, Inc. Clinical Trials and PubMed Articles about Glooko, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Glooko, Inc. Companies in our database. You can also find out about relevant Glooko, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topic

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...

Corporate Database Quicklinks

Searches Linking to this Company Record